Search Results 1131-1140 of 17111 for egfr

  1. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  2. Early-Onset Colorectal Cancer Group - Specialty groups - Mayo Clinic

    Mayo Clinic's Early-Onset Colorectal Cancer Group offers advanced care for young people with colorectal cancers.

  3. Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE) - Mayo Clinic

    The purpose of the study is to compare the effects, good and/or bad, of a treatment for removing kidney stones called the SURE procedure for stone evacuation to ...

  4. Publications - Kedar G. Sharbidre, M.D. - Mayo Clinic

    Konstantinoff KS, Ludwig DR, Sharbidre K, Arif-Tiwari H, Itani M. Gallbladder and biliary pathology: lessons learned from multidisciplinary conference.

  5. Evaluation of the Phased Radio Frequency Ablation System - Mayo Clinic

    About this study. VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study.

  6. Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging - Mayo Clinic

    Congestive heart failure (CHF) affects nearly 5 million Americans and claims more than 300,000 lives annually. A primary pathophysiologic mechanism in this ...

  7. Early Feasibility of Endoscopic Gastric Mucosal Ablation (GMA) as a Primary Obesity Therapy - Mayo Clinic

    Known moderate or severe chronic kidney disease (CKD), with estimated glomerular filtration rate (eGFR) \<45 ml/min/1.73m2 (estimated by MDRD). 34. Known ...

  8. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  9. A Study to Evaluate the Safety and Effectiveness of DCR-PHXC to Treat Patients with Primary Hyperoxaluria Type 1 or 2 and Severe Renal Impairment - Mayo Clinic

    The purpose of this study is to evaluate DCR-PHXC in patients with primary hyperoxaluria type 1 (PH1) and severe renal impairment, with or without dialysis.

  10. MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment - Mayo Clinic

    MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure ...